Critical roles for light and its receptors in generating T cell-mediated immunity during Leishmania Donovani infection

PLoS Pathogens

Volumn 7, Issue 10, 2011, Pages

  Stanley, Amanda C ^a,b   de Labastida Rivera, Fabian ^a   Haque, Ashraful ^a   Sheel, Meru ^a   Zhou, Yonghong ^a   Amante, Fiona H ^a   Bunn, Patrick T ^a   Randall, Louise M ^a,c   Pfeffer, Klaus ^d   Scheu, Stefanie ^d   Hickey, Michael J ^e   Saunders, Bernadette M ^f   Ware, Carl ^g   Hill, Geoff R ^a   Tamada, Koji ^h   Kaye, Paul M ⁱ   Engwerda, Christian R ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e MONASH UNIVERSITY   (Australia)

^f CENTENARY INSTITUTE   (Australia)

^g Infectious and Inflammatory Diseases Centre   (Australia)

^h UNIVERSITY OF MARYLAND   (United States)

ⁱ UNIVERSITY OF YORK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HERPESVIRUS ENTRY MEDIATOR; HERPESVIRUS ENTRY MEDIATOR LIGAND; INTERLEUKIN 12; INTERLEUKIN 23; PROTEIN P40; TUMOR NECROSIS FACTOR; LYMPHOTOXIN BETA RECEPTOR; MONOCLONAL ANTIBODY; TNFSF14 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HEPATITIS; INFECTION CONTROL; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VISCERAL LEISHMANIASIS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL PROLIFERATION; DRUG EFFECT; GENETICS; IMMUNOLOGY; LEISHMANIA DONOVANI; LIVER; METABOLISM; MOUSE MUTANT; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; T LYMPHOCYTE;

HERPESVIRIDAE; LEISHMANIA DONOVANI; MUS; PROTOZOA;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-23; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIVER; LYMPHOTOXIN BETA RECEPTOR; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

EID: 80055077512     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002279     Document Type: Article

References (66)

1. Locksley RM, Killeen N, Lenardo MJ, (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104: 487-501.
2. Aggarwal BB, (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3: 745-756.
3. Ware CF, (2005) Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 23: 787-819.
4. Ware CF, (2008) Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol Rev 223: 186-201.
5. Aggarwal BB, Eessalu TE, Hass PE, (1985) Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon. Nature 318: 665-667.
6. Ruuls SR, Hoek RM, Ngo VN, McNeil T, Lucian LA, et al. (2001) Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 15: 533-543.
7. Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, et al. (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8: 21-30.
8. Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, et al. (1994) A lymphotoxin-beta-specific receptor. Science 264: 707-710.
9. Harrop JA, McDonnell PC, Brigham-Burke M, Lyn SD, Minton J, et al. (1998) Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem 273: 27548-27556.
10. Zhai Y, Guo R, Hsu TL, Yu GL, Ni J, et al. (1998) LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest 102: 1142-1151.
11. Sedy JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, et al. (2005) B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 6: 90-98.
12. Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, et al. (2008) CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 9: 176-185.
13. Whitbeck JC, Peng C, Lou H, Xu R, Willis SH, et al. (1997) Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J Virol 71: 6083-6093.
14. Murphy TL, Murphy KM, (2010) Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM. Annu Rev Immunol 28: 389-411.
15. Cheung TC, Steinberg MW, Oborne LM, Macauley MG, Fukuyama S, et al. (2009) Unconventional ligand activation of herpesvirus entry mediator signals cell survival. Proc Natl Acad Sci U S A 106: 6244-6249.
16. Otterdal K, Smith C, Oie E, Pedersen TM, Yndestad A, et al. (2006) Platelet-derived LIGHT induces inflammatory responses in endothelial cells and monocytes. Blood 108: 928-935.
17. Kwon BS, Wang S, Udagawa N, Haridas V, Lee ZH, et al. (1998) TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. Faseb J 12: 845-854.
18. Marsters SA, Ayres TM, Skubatch M, Gray CL, Rothe M, et al. (1997) Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem 272: 14029-14032.
19. Browning JL, Sizing ID, Lawton P, Bourdon PR, Rennert PD, et al. (1997) Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. J Immunol 159: 3288-3298.
20. Kabashima K, Banks TA, Ansel KM, Lu TT, Ware CF, et al. (2005) Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells. Immunity 22: 439-450.
21. Schneider K, Loewendorf A, De Trez C, Fulton J, Rhode A, et al. (2008) Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe 3: 67-76.
22. Ehlers S, Holscher C, Scheu S, Tertilt C, Hehlgans T, et al. (2003) The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes. J Immunol 170: 5210-5218.
23. Murray HW, Berman JD, Davies CR, Saravia NG, (2005) Advances in leishmaniasis. Lancet 366: 1561-1577.
24. Stanley AC, Engwerda CR, (2007) Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol 85: 138-147.
25. Murray HW, Jungbluth A, Ritter E, Montelibano C, Marino MW, (2000) Visceral leishmaniasis in mice devoid of tumor necrosis factor and response to treatment. Infect Immun 68: 6289-6293.
26. Engwerda CR, Ato M, Stager S, Alexander CE, Stanley AC, et al. (2004) Distinct roles for lymphotoxin-alpha and tumor necrosis factor in the control of Leishmania donovani infection. Am J Pathol 165: 2123-2133.
27. Tumang MC, Keogh C, Moldawer LL, Helfgott DC, Teitelbaum R, et al. (1994) Role and effect of TNF-alpha in experimental visceral leishmaniasis. J Immunol 153: 768-775.
28. Engwerda CR, Kaye PM, (2000) Organ-specific immune responses associated with infectious disease. Immunol Today 21: 73-78.
29. Engwerda CR, Ato M, Kaye PM, (2004) Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis. Trends Parasitol 20: 524-530.
30. Kaye PM, Svensson M, Ato M, Maroof A, Polley R, et al. (2004) The immunopathology of experimental visceral leishmaniasis. Immunol Rev 201: 239-253.
31. Engwerda CR, Ato M, Cotterell SE, Mynott TL, Tschannerl A, et al. (2002) A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection. Am J Pathol 161: 429-437.
32. Ato M, Stager S, Engwerda CR, Kaye PM, (2002) Defective CCR7 expression on dendritic cells contributes to the development of visceral leishmaniasis. Nat Immunol 3: 1185-1191.
33. Squires KE, Schreiber RD, McElrath MJ, Rubin BY, Anderson SL, et al. (1989) Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. J Immunol 143: 4244-4249.
34. Murray HW, Nathan CF, (1999) Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 189: 741-746.
35. Anand S, Wang P, Yoshimura K, Choi IH, Hilliard A, et al. (2006) Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis. J Clin Invest 116: 1045-1051.
36. Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, et al. (2002) The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17: 525-535.
37. De Trez C, Schneider K, Potter K, Droin N, Fulton J, et al. (2008) The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells. J Immunol 180: 238-248.
38. Gorak PM, Engwerda CR, Kaye PM, (1998) Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol 28: 687-695.
39. Engwerda CR, Murphy ML, Cotterell SE, Smelt SC, Kaye PM, (1998) Neutralization of IL-12 demonstrates the existence of discrete organ- specific phases in the control of Leishmania donovani. Eur J Immunol 28: 669-680.
40. Murray HW, (1997) Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. J Infect Dis 175: 1477-1479.
41. Trinchieri G, (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13: 251-276.
42. Polley R, Stager S, Prickett S, Maroof A, Zubairi S, et al. (2006) Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen. Infect Immun 74: 773-776.
43. Smelt SC, Cotterell SE, Engwerda CR, Kaye PM, (2000) B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology. J Immunol 164: 3681-3688.
44. McElrath MJ, Murray HW, Cohn ZA, (1988) The dynamics of granuloma formation in experimental visceral leishmaniasis. J Exp Med 167: 1927-1937.
45. Alexander CE, Kaye PM, Engwerda CR, (2001) CD95 is required for the early control of parasite burden in the liver of Leishmania donovani-infected mice. Eur J Immunol 31: 1199-1210.
46. Tamada K, Shimozaki K, Chapoval AI, Zhai Y, Su J, et al. (2000) LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 164: 4105-4110.
47. Tamada K, Shimozaki K, Chapoval AI, Zhu G, Sica G, et al. (2000) Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat Med 6: 283-289.
48. Wang J, Lo JC, Foster A, Yu P, Chen HM, et al. (2001) The regulation of T cell homeostasis and autoimmunity by T cell-derived LIGHT. J Clin Invest 108: 1771-1780.
49. Shaikh RB, Santee S, Granger SW, Butrovich K, Cheung T, et al. (2001) Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol 167: 6330-6337.
50. Engwerda CR, Smelt SC, Kaye PM, (1996) An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice. Exp Parasitol 84: 195-202.
51. Xu G, Liu D, Okwor I, Wang Y, Korner H, et al. (2007) LIGHT Is critical for IL-12 production by dendritic cells, optimal CD4+ Th1 cell response, and resistance to Leishmania major. J Immunol 179: 6901-6909.
52. Randall LM, Amante FH, Zhou Y, Stanley AC, Haque A, et al. (2008) Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA. J Immunol 181: 7458-7462.
53. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, et al. (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187: 601-608.
54. Geissmann F, Auffray C, Palframan R, Wirrig C, Ciocca A, et al. (2008) Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol 86: 398-408.
55. Cheong C, Matos I, Choi JH, Dandamudi DB, Shrestha E, et al. (2010) Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 143: 416-429.
56. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, et al. (1992) RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
57. Scheu S, Alferink J, Potzel T, Barchet W, Kalinke U, et al. (2002) Targeted disruption of LIGHT causes defects in costimulatory T cell activation and reveals cooperation with lymphotoxin beta in mesenteric lymph node genesis. J Exp Med 195: 1613-1624.
58. Korner H, Cook M, Riminton DS, Lemckert FA, Hoek RM, et al. (1997) Distinct roles for lymphotoxin-alpha and tumor necrosis factor in organogenesis and spatial organization of lymphoid tissue. Eur J Immunol 27: 2600-2609.
59. Barnden MJ, Allison J, Heath WR, Carbone FR, (1998) Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76: 34-40.
60. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
61. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, et al. (1993) Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742.
62. Cui J, Shin T, Kawano T, Sato H, Kondo E, et al. (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278: 1623-1626.
63. Stanley AC, Dalton JE, Rossotti SH, MacDonald KP, Zhou Y, et al. (2008) VCAM-1 and VLA-4 modulate dendritic cell IL-12p40 production in experimental visceral leishmaniasis. PLoS Pathog 4: e1000158.
64. Haque A, Stanley AC, Amante FH, Rivera Fde L, Zhou Y, et al. (2010) Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity. J Immunol 184: 2583-2592.
65. Stanley AC, Zhou Y, Amante FH, Randall LM, Haque A, et al. (2008) Activation of invariant NKT cells exacerbates experimental visceral leishmaniasis. PLoS Pathog 4: e1000028.
66. Sanjo H, Zajonc DM, Braden R, Norris PS, Ware CF, (2010) Allosteric regulation of the ubiquitin:NIK and ubiquitin:TRAF3 E3 ligases by the lymphotoxin-beta receptor. J Biol Chem 285: 17148-17155.